Agreed, but Cooley's name isn't the best right now so he needs to pick it up a notch on this Baby. As long as the OTC and NVSOS gets updated soon and he follows through with a PR on what this intends to be moving forward, there won't be a reason for a negative misinformation campaign.
Market Data 
Markets 
AI
